There’s been a lot of buzz the last few days about reviving the dead via stem cells. Is this possible? Who knows, but it would be very long odds. Could it lead to zombies? Not really, but there could be negative outcomes even if it seems to sorta work (more below). Bioquark, Inc. is a […]
Beyond zombies: reviving dead people with stem cells & lasers? Read More »
A team at the University of Miami has launched a claimed first of its kind stem cell clinic trial for Alzheimer’s Disease (AD). The trial seems somewhat unique in using mesenchymal stem cells (MSC) for AD and is being run with biotech Longeveron. You can read more on the actual clinic trial including all the
New Stem Cell Clinic Trial for Alzheimer’s: Perspectives & Questions Read More »
Should we be injecting bone marrow cells into someone’s eyes? it seems like a terrible idea to me based on what we currently know. Whenever I see a stem cell headline like this one from a recent Baltimore Sun piece, it raises many questions: Stem cells apparently reverse woman’s blindness. First of all, is the reporter,
Study injects marrow cells into eye, charges $20K Read More »
Can stem cells mend a broken heart via cardiac regenerative medicine? The idea of the use of stem cells and regenerative medicine strategies for heart disease has taken us on a roller coaster ride over the years. There are many controversial questions still such as whether the adult heart has meaningful populations of endogenous stem
Stem Cells on Valentine’s Day: Cardiac Regenerative Medicine Read More »
Clinical research on Type I Diabetes is one of the most exciting and promising areas of stem cells and regenerative medicine for human disease. Two of the coolest companies out there in this arena have been ViaCyte and BetaLogics (owned by J&J). For more on ViaCyte see my interview with President and CEO Paul Laikind
ViaCyte on the Rise: First Diabetes Trial Data & Acquires BetaLogics IP Read More »
For the first time to my knowledge, a patient has sued an American stem cell clinic, US Stem Cell, alleging damage to her eyes from fat stem cell injections. Just a few months ago, there was a report of a Japanese patient who sued a fat stem cell clinic and won, but I’m not aware
US stem cell clinic sued for injection into eyes Read More »
Editor’s note: this is a guest post on the US stem cell environment. By Heather Main I moved to the San Diego from Australia in August 2015, and Paul asked me if I could write something on my first impressions of doing science in the US, as opposed to other countries I have worked/studied in
First impressions of the US stem cell environment from an Aussie Read More »
In 2014, I reported on a groundbreaking, but debated Duke stem cell-based clinical trial being launched for autism. Where does that trial stand today? (note that as of 2018-2020 I am very skeptical about stem cells for autism) The cord blood trial has continued. It is led by Dr. Joanne Kurtzberg, whom I interviewed about cord blood stem
Upbeat Update from Duke on Stem Cell Autism Trial, but Questions Remain Read More »
For years I have been working to educate the community about the predatory stem cell clinics out there. These clinics prey on vulnerable patients and their families. The clinics use hope as a marketing tool. A weapon. As the number of such clinics has mushroomed in the US and elsewhere the risk to both patients
Predatory stem cell clinics are winning: what can we do? Read More »
A stem cell biotech in the news this week was one that had mostly flown under the radar previously with aim to zap cancer stem cells. Stemcentrx has a focus on killing cancer stem cells as a novel approach to treating cancer. Antonio Regalado had a nice article yesterday on the company. He reports that Stemcentrx has
Can Stemcentrx thrive as a biotech killing cancer stem cells? Read More »